The RFPL4A gene, previously linked to colorectal cancer, has gained attention in Japanese research for its potential role in chemotherapy resistance in G1 phase individuals.41 This discovery suggests RFPL4A could be a new target for challenging cancer diseases. This evidence concerns the gene RFPL4A and colorectal cancer.